Over 1/3 of adults meet criteria for metabolic syndrome and numbers only continue to grow. Daniel Melville, M.D. examines the biological mechanisms behind this syndrome and discusses how supporting the Endocannabinoid System with full spectrum cannabinoids may improve your patients' quality of life.